Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06230354
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-18
First Post:
2024-01-08
Brief Title:
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Sponsor:
Imperial College London
Organization:
Imperial College London
Organization Data
Organization:
Imperial College London
Class:
OTHER
Study ID:
1007564
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Imperial College London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |